Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes

Molecular Brain Research

Volumn 100, Issue 1-2, 2002, Pages 103-117

  Muir, E M ^a   Adcock, K H ^a   Morgenstern, D A ^a   Clayton, R ^a   Von Stillfried, N ^a   Rhodes, K ^a   Ellis, C ^a   Fawcett, J W ^a   Rogers, J H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Brain injury; Cortex; Cytokines; Glia; MMPs; TIMP proteases

Indexed keywords

CYTOKINE; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN INJURY; CELL ACTIVATION; CELL CULTURE; CELL MIGRATION; CELL POPULATION; CONTROLLED STUDY; ENZYME SYNTHESIS; GLIA CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INCUBATION TIME; NERVE FIBER REGENERATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SCHWANN CELL; WESTERN BLOTTING; WHITE MATTER;

ANIMALS; ANIMALS, NEWBORN; ANTIBODY SPECIFICITY; ASTROCYTES; BRAIN; BRAIN INJURIES; CELLS, CULTURED; CEREBRAL CORTEX; CYTOKINES; GLIOSIS; GROWTH CONES; IN SITU HYBRIDIZATION; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; NERVE REGENERATION; PROTEOCHONDROITIN SULFATES; RATS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TISSUE INHIBITOR OF METALLOPROTEINASES; UP-REGULATION;

EID: 0037197736     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00132-8     Document Type: Article

References (95)

1. Expression of MMPs and TIMPs in human optic nerve head astrocytes
2. In situ hybridization to cellular RNA with radiolabelled RNA probes
3. Differential MMP expression in cases of multiple sclerosis and stroke
4. Neurocan is up-regulated in injured brain and in cytokine-treated astrocytes
5. Effects of TGF-β1 on the extracellular matrix and cytoskeleton of cultured astrocytes
6. Nervous system proteoglycans as modulators of neurite outgrowth
7. Tissue inhibitors of metalloproteinases: Evolution, structure and function
8. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve
9. Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines
10. Meeting report: Matrix metalloproteases and their inhibitors in the nervous system
11. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia
12. Review: MMPs and the development of cancer
13. The expression of tPA, MMPs, and endogenous inhibitors in the CNS in multiple sclerosis: Comparison of stages in lesion evolution
14. Metalloprotease increases in the injured rat spinal cord
15. Localization of proteinase expression in the developing rabbit brain
16. Inhibition of neurite growth by the NG2 CSPG
17. Resistance of young gelatinase B-deficient mice to EAE and necrotizing tail lesions
18. Differential spatial distribution and temporal regulation of TIMP mRNA expression during rat CNS development
19. MMP-2 and MMP-9 increase the neurite-promoting potential of Schwann cell basal laminae and are upregulated in degenerated nerve
20. Comparing astrocytic cell lines that are inhibitory or permissive to axon growth: The major axon-inhibitory proteoglycan is NG2
21. The catabolism of extracellular matrix components
22. An analysis of astrocytic cell lines with different abilities to promote axon growth
23. Cytokine-induced changes in the ability of astrocytes to support migration of oligodendrocyte precursors and axon growth
24. The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth
25. Injury-induced gelatinase and thrombin-like activities in regenerating and non-regenerating nervous systems
26. DSD-1 proteoglycan is the mouse homolog of phosphacan and displays opposing effects on neurite outgrowth dependent on neuronal lineage
27. Early appearance of activated MMP-9 after focal cerebral ischemia in mice: A possible role in blood-brain barrier dysfunction
28. Antigenic and functional characterization of a rat CNS-derived cell line immortalized by a retroviral vector
29. T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: Relevance to HTLV-I-induced neurological disease
30. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
31. Increased production of gelatinase-B (MMP-9) and interleukin-6 by activated rat microglia in culture
32. Cytokines regulate gelatinase A and B (MMP2 and 9) activity in cultured rat astrocytes
33. Regulation of MMP expression in astrocytes, microglia, and neurons
34. Entorhinal cortex lesion in adult rats induces the expression of the neuronal CSPG neurocan in reactive astrocytes
35. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia
36. Binding of active (57 kDa) (MT1-MMP) to (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation
37. Cytokines and the nervous system I: Expression and recognition
38. Neuronal excitation-driven and AP-1-dependent activation of TIMP-1 gene expression in rodent hippocampus
39. Differential regulation of TIMP mRNA expression in response to intracranial injury
40. Matrix metalloproteinases in tumor invasion
41. Localization of the functional domains of human TIMP-3 and the effects of a Sorsby's Fundus Dystrophy mutation
42. Altered balance between MMPs and their inhibitors in experimental biliary fibrosis
43. Basement membrane and repair of injury to peripheral nerve: Defining a potential role for macrophages, MMPs, and TIMP-1
44. Differential regulation of murine TIMP-1 and TIMP-2 expression in normal and ras-transformed cell lines
45. Murine TIMP-4: CDNA isolation and expression in adult mouse tissues
46. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis
47. MMP stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells
48. Transforming growth factor-β1 and basic fibroblast growth factor in the injured CNS
49. Review: Growth factors in CNS repair and regeneration
50. Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat
51. Matrix metalloproteinases in the normal human central-nervous system, microglial nodules, and multiple-sclerosis lesions
52. Aggrecan-versican-neurocan family of proteoglycans
53. CSPGs as mediators of axon growth and pathfinding
54. Cellular signaling roles of TGFβ, TNFα and bAPP in brain injury responses and Alzheimer's disease
55. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue
56. Degradation of underlying extracellular matrix by sensory neurons during neurite outgrowth
57. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes
58. Cytokines in inflammatory brain lesions: Helpful and harmful
59. Interactions of the CSPG phosphacan with neurons, glia, and neural CAMs
60. Metalloprotease-dependent neurite outgrowth within a synthetic extracellular matrix is induced by NGF
61. Schwannoma cell-derived inhibitor of the neurite-promoting activity of laminin
62. Evaluation of some newer MMPs
63. Bovine CNS myelin contains neurite growth-inhibitory activity associated with CSPGs
64. The metalloproteinase Stromelysin-1 (Transin) mediates PC12 cell growth cone invasiveness through basal laminae
65. MMP-9/gelatinase B is required for process outgrowth by oligodendrocytes
66. Differential expression of MMP and TIMP genes in the mouse CNS in normal and inflammatory states
67. Release of plasminogen activator and a calcium-dependent metalloprotease from cultured sympathetic and sensory neurons
68. Neurite penetration into collagen gels requires Ca-dependent metalloproteinase activity
69. TIMP-1 is differentially induced in neurons and astrocytes after seizures: Evidence for developmental, immediate early gene, and lesion response
70. MMP expression increases after cerebral focal ischemia in rats - Inhibition of MMP-9 reduces infarct size
71. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase
72. Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain
73. Matrix metalloproteinases in brain injury
74. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain
75. Cytokines and the nervous system 11: Actions and mechanisms of action
76. Interleukin-1 in the brain: Biology, pathology and therapeutic target
77. Brain-derived versican V2 is a potent inhibitor of axonal growth
78. Inhibitors of neurite growth
79. Induction of MMPs following brain injury in rats
80. An inhibitor of neurite outgrowth produced by astrocytes
81. Up-regulation of TIMP-3 gene expression by TGF-beta in articular chondrocytes is mediated by serine/threonine and tyrosine kinases
82. Oligodendrocytes utilize MMP-9 to extend processes along an astrocyte extracellular matrix
83. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum
84. Effects of MMP-9 gene knockout on morphological and motor outcomes after traumatic brain injury
85. Subtractive cloning identifies TIMP-1 increased gene expression following focal stroke
86. Quantitation of MMPs in cultured rat astrocytes using the PCR with a multi-competitor cDNA standard
87. A GDNF-secreting clone of the Schwann cell line SCTM41 enhances survival and fibre outgrowth from embryonic nigral neurons grafted to the striatum and the lesioned substantia nigra
88. Human skin fibroblast stromelysin
89. Selective localization of gelatinase A, an enzyme degrading beta-amyloid protein, in white matter microglia and in Schwann cells
90. The brain CSPG brevican associates with astrocytes ensheathing cerebellar glomeruli and inhibits neurite outgrowth from granule neurons
91. Review: Lecticans: Organizers of the brain extracellular matrix
92. Matrix metalloproteases and diseases of the CNS
93. Neuronal MMP-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan
94. Degradation of chondroitin sulfate proteoglycan enhances the neurite-promoting potential of spinal cord tissue